Clear cell sarcoma of soft tissues in children and young adults: The St. Jude Children's Research Hospital experience

Sudha Parasuraman, Bhaskar N. Rao, Sara Bodner, Alvida Cain, Charles B. Pratt, Thomas E. Merchant, Alberto S. Pappo

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Clear cell sarcoma is a rare soft tissue neoplasm whose clinical behavior and outcome has not been previously characterized. This study reviewed the clinical characteristics and outcome of all children with clear cell sarcoma of the soft tissues who were treated at St. Jude Children's Research Hospital from March 1962 through August 1998. Of 225 children with nonrhabdomyosarcomatous soft tissue sarcomas, 5 (2.2%) were diagnosed with clear cell sarcoma. Median age at diagnosis was 15 years 3 months. Primary sites included the extremities (n = 3), chest wall (n = 1), and abdomen (n = 1). At diagnosis 3 patients had localized disease. Following surgical resection (n = 3), radiotherapy (n = 2), and chemotherapy (n = 1) all three survive disease-free 10, 11, and 90 months after diagnosis, respectively. The remaining two patients with metastatic disease at diagnosis died 21 days and 9 months after diagnosis. Clear cell sarcoma of the soft tissues is rare in pediatrics. Complete surgical resection with negative margins is the most effective treatment for this disease. Patients with metastatic disease are candidates for multiinstitutional chemotherapy trials.

Original languageEnglish
Pages (from-to)539-544
Number of pages6
JournalPediatric Hematology and Oncology
Volume16
Issue number6
DOIs
StatePublished - Nov 1 1999

Fingerprint

Clear Cell Sarcoma
Young Adult
Tissue
Research
Chemotherapy
Soft Tissue Neoplasms
Drug Therapy
Pediatrics
Radiotherapy
Thoracic Wall
Sarcoma
Abdomen
Extremities
Young adults

Keywords

  • Clear cell sarcoma
  • Pediatric

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology
  • Cancer Research
  • Management of Technology and Innovation

Cite this

Clear cell sarcoma of soft tissues in children and young adults : The St. Jude Children's Research Hospital experience. / Parasuraman, Sudha; Rao, Bhaskar N.; Bodner, Sara; Cain, Alvida; Pratt, Charles B.; Merchant, Thomas E.; Pappo, Alberto S.

In: Pediatric Hematology and Oncology, Vol. 16, No. 6, 01.11.1999, p. 539-544.

Research output: Contribution to journalArticle

Parasuraman, Sudha ; Rao, Bhaskar N. ; Bodner, Sara ; Cain, Alvida ; Pratt, Charles B. ; Merchant, Thomas E. ; Pappo, Alberto S. / Clear cell sarcoma of soft tissues in children and young adults : The St. Jude Children's Research Hospital experience. In: Pediatric Hematology and Oncology. 1999 ; Vol. 16, No. 6. pp. 539-544.
@article{6a7e5328443d4951b522fadbbbde249a,
title = "Clear cell sarcoma of soft tissues in children and young adults: The St. Jude Children's Research Hospital experience",
abstract = "Clear cell sarcoma is a rare soft tissue neoplasm whose clinical behavior and outcome has not been previously characterized. This study reviewed the clinical characteristics and outcome of all children with clear cell sarcoma of the soft tissues who were treated at St. Jude Children's Research Hospital from March 1962 through August 1998. Of 225 children with nonrhabdomyosarcomatous soft tissue sarcomas, 5 (2.2{\%}) were diagnosed with clear cell sarcoma. Median age at diagnosis was 15 years 3 months. Primary sites included the extremities (n = 3), chest wall (n = 1), and abdomen (n = 1). At diagnosis 3 patients had localized disease. Following surgical resection (n = 3), radiotherapy (n = 2), and chemotherapy (n = 1) all three survive disease-free 10, 11, and 90 months after diagnosis, respectively. The remaining two patients with metastatic disease at diagnosis died 21 days and 9 months after diagnosis. Clear cell sarcoma of the soft tissues is rare in pediatrics. Complete surgical resection with negative margins is the most effective treatment for this disease. Patients with metastatic disease are candidates for multiinstitutional chemotherapy trials.",
keywords = "Clear cell sarcoma, Pediatric",
author = "Sudha Parasuraman and Rao, {Bhaskar N.} and Sara Bodner and Alvida Cain and Pratt, {Charles B.} and Merchant, {Thomas E.} and Pappo, {Alberto S.}",
year = "1999",
month = "11",
day = "1",
doi = "10.1080/088800199276831",
language = "English",
volume = "16",
pages = "539--544",
journal = "Pediatric Hematology and Oncology",
issn = "0888-0018",
publisher = "Informa Healthcare",
number = "6",

}

TY - JOUR

T1 - Clear cell sarcoma of soft tissues in children and young adults

T2 - The St. Jude Children's Research Hospital experience

AU - Parasuraman, Sudha

AU - Rao, Bhaskar N.

AU - Bodner, Sara

AU - Cain, Alvida

AU - Pratt, Charles B.

AU - Merchant, Thomas E.

AU - Pappo, Alberto S.

PY - 1999/11/1

Y1 - 1999/11/1

N2 - Clear cell sarcoma is a rare soft tissue neoplasm whose clinical behavior and outcome has not been previously characterized. This study reviewed the clinical characteristics and outcome of all children with clear cell sarcoma of the soft tissues who were treated at St. Jude Children's Research Hospital from March 1962 through August 1998. Of 225 children with nonrhabdomyosarcomatous soft tissue sarcomas, 5 (2.2%) were diagnosed with clear cell sarcoma. Median age at diagnosis was 15 years 3 months. Primary sites included the extremities (n = 3), chest wall (n = 1), and abdomen (n = 1). At diagnosis 3 patients had localized disease. Following surgical resection (n = 3), radiotherapy (n = 2), and chemotherapy (n = 1) all three survive disease-free 10, 11, and 90 months after diagnosis, respectively. The remaining two patients with metastatic disease at diagnosis died 21 days and 9 months after diagnosis. Clear cell sarcoma of the soft tissues is rare in pediatrics. Complete surgical resection with negative margins is the most effective treatment for this disease. Patients with metastatic disease are candidates for multiinstitutional chemotherapy trials.

AB - Clear cell sarcoma is a rare soft tissue neoplasm whose clinical behavior and outcome has not been previously characterized. This study reviewed the clinical characteristics and outcome of all children with clear cell sarcoma of the soft tissues who were treated at St. Jude Children's Research Hospital from March 1962 through August 1998. Of 225 children with nonrhabdomyosarcomatous soft tissue sarcomas, 5 (2.2%) were diagnosed with clear cell sarcoma. Median age at diagnosis was 15 years 3 months. Primary sites included the extremities (n = 3), chest wall (n = 1), and abdomen (n = 1). At diagnosis 3 patients had localized disease. Following surgical resection (n = 3), radiotherapy (n = 2), and chemotherapy (n = 1) all three survive disease-free 10, 11, and 90 months after diagnosis, respectively. The remaining two patients with metastatic disease at diagnosis died 21 days and 9 months after diagnosis. Clear cell sarcoma of the soft tissues is rare in pediatrics. Complete surgical resection with negative margins is the most effective treatment for this disease. Patients with metastatic disease are candidates for multiinstitutional chemotherapy trials.

KW - Clear cell sarcoma

KW - Pediatric

UR - http://www.scopus.com/inward/record.url?scp=0032725427&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032725427&partnerID=8YFLogxK

U2 - 10.1080/088800199276831

DO - 10.1080/088800199276831

M3 - Article

C2 - 10599094

AN - SCOPUS:0032725427

VL - 16

SP - 539

EP - 544

JO - Pediatric Hematology and Oncology

JF - Pediatric Hematology and Oncology

SN - 0888-0018

IS - 6

ER -